Radiotheranostics Market Size, Share & Trends Report

Radiotheranostics Market (2026 - 2033) Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Non-Oncology), By Region, And Segment Forecasts

Market Segmentation

Radiotheranostics Radioisotope Outlook (Revenue, USD Million, 2021 - 2033)
- Iodine-131
- Iodine-123
- Gallium-68
- Lutetium-177
- 18F with Y-90
- Others
Radiotheranostics Approach Outlook (Revenue, USD Million, 2021 - 2033)
- Targeted Therapeutic
- Targeted Diagnostic
Radiotheranostics Application Outlook (Revenue, USD Million, 2021 - 2033)
- Oncology
  - Thyroid Cancer
  - Neuroendocrine Tumor
  - Hepatocellular Carcinoma
  - Prostate Cancer
  - Others
- Non-Oncology
  - Neurological Disorders
  - Arthritis
  - Others
Radiotheranostics Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Radiotheranostics Market, by Radioisotope
    - Iodine-131
    - Iodine-123
    - Gallium-68
    - Lutetium-177
    - 18F with Y-90
    - Others
  - North America Radiotheranostics Market, by Approach
    - Targeted Therapeutic
    - Targeted Diagnostic
  - North America Radiotheranostics Market, by Application
    - Oncology
      - Thyroid Cancer
      - Neuroendocrine Tumor
      - Hepatocellular Carcinoma
      - Prostate Cancer
      - Others
    - Non-Oncology
      - Neurological Disorders
      - Arthritis
      - Others
  - U.S.
    - U.S. Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - U.S. Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - U.S. Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Canada
    - Canada Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Canada Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Canada Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Mexico
    - Mexico Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Mexico Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Mexico Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
- Europe
  - Europe Radiotheranostics Market, by Radioisotope
    - Iodine-131
    - Iodine-123
    - Gallium-68
    - Lutetium-177
    - 18F with Y-90
    - Others
  - Europe Radiotheranostics Market, by Approach
    - Targeted Therapeutic
    - Targeted Diagnostic
  - Europe Radiotheranostics Market, by Application
    - Oncology
      - Thyroid Cancer
      - Neuroendocrine Tumor
      - Hepatocellular Carcinoma
      - Prostate Cancer
      - Others
    - Non-Oncology
      - Neurological Disorders
      - Arthritis
      - Others
  - UK
    - UK Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - UK Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - UK Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Germany
    - Germany Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Germany Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Germany Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - France
    - France Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - France Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - France Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Italy
    - Italy Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Italy Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Italy Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Spain
    - Spain Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Spain Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Spain Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Denmark
    - Denmark Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Denmark Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Denmark Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Sweden
    - Sweden Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Sweden Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Sweden Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Norway
    - Norway Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Norway Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Norway Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
- Asia Pacific
  - Asia Pacific Radiotheranostics Market, by Radioisotope
    - Iodine-131
    - Iodine-123
    - Gallium-68
    - Lutetium-177
    - 18F with Y-90
    - Others
  - Asia Pacific Radiotheranostics Market, by Approach
    - Targeted Therapeutic
    - Targeted Diagnostic
  - Asia Pacific Radiotheranostics Market, by Application
    - Oncology
      - Thyroid Cancer
      - Neuroendocrine Tumor
      - Hepatocellular Carcinoma
      - Prostate Cancer
      - Others
    - Non-Oncology
      - Neurological Disorders
      - Arthritis
      - Others
  - China
    - China Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - China Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - China Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Japan
    - Japan Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Japan Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Japan Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - India
    - India Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - India Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - India Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Australia
    - Australia Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Australia Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Australia Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - South Korea
    - South Korea Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - South Korea Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - South Korea Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Thailand
    - Thailand Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Thailand Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Thailand Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
- Latin America
  - Latin America Radiotheranostics Market, by Radioisotope
    - Iodine-131
    - Iodine-123
    - Gallium-68
    - Lutetium-177
    - 18F with Y-90
    - Others
  - Latin America Radiotheranostics Market, by Approach
    - Targeted Therapeutic
    - Targeted Diagnostic
  - Latin America Radiotheranostics Market, by Application
    - Oncology
      - Thyroid Cancer
      - Neuroendocrine Tumor
      - Hepatocellular Carcinoma
      - Prostate Cancer
      - Others
    - Non-Oncology
      - Neurological Disorders
      - Arthritis
      - Others
  - Brazil
    - Brazil Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Brazil Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Brazil Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Argentina
    - Argentina Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Argentina Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Argentina Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
- Middle East & Africa
  - Middle East & Africa Radiotheranostics Market, by Radioisotope
    - Iodine-131
    - Iodine-123
    - Gallium-68
    - Lutetium-177
    - 18F with Y-90
    - Others
  - Middle East & Africa Radiotheranostics Market, by Approach
    - Targeted Therapeutic
    - Targeted Diagnostic
  - Middle East & Africa Radiotheranostics Market, by Application
    - Oncology
      - Thyroid Cancer
      - Neuroendocrine Tumor
      - Hepatocellular Carcinoma
      - Prostate Cancer
      - Others
    - Non-Oncology
      - Neurological Disorders
      - Arthritis
      - Others
  - South Africa
    - South Africa Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - South Africa Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - South Africa Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Saudi Arabia
    - Saudi Arabia Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Saudi Arabia Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Saudi Arabia Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - UAE
    - UAE Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - UAE Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - UAE Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others
  - Kuwait
    - Kuwait Radiotheranostics Market, by Radioisotope
      - Iodine-131
      - Iodine-123
      - Gallium-68
      - Lutetium-177
      - 18F with Y-90
      - Others
    - Kuwait Radiotheranostics Market, by Approach
      - Targeted Therapeutic
      - Targeted Diagnostic
    - Kuwait Radiotheranostics Market, by Application
      - Oncology
        
        Thyroid Cancer
        
        Neuroendocrine Tumor
        
        Hepatocellular Carcinoma
        
        Prostate Cancer
        
        Others
      - Non-Oncology
        
        Neurological Disorders
        
        Arthritis
        
        Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments